Along with its commitment towards ‘Healthcare for All’, Lincoln Pharmaceuticals Limited has launched chewable Vitamin C + Zinc tablet for the markets in India. The tablet is an evidence-based bio-active for natural immunity in the combination of zinc that boosts antiviral activity and protection against COVID 19. Market size for Vitamin C and Zinc tablets is estimated at around Rs. 150-crore in India and growing at 15% per annum.
“During this COVID 19 Pandemic, immunity & immunity boosters are the only way to protect against the Virus. Vitamin-C & Zinc tablet has become a necessity and important part of all human being in their day to day life. With this launch, we aim to fill the gaps in serving the healthcare requirement of the masses with our wide range of 600 plus formulations. As it is in the form of Chewable Tablet, Geriatric and pediatric patients and travelling patients who may not have ready access to water are most need of easy swallowing dosage forms like chewable tablets with pleasant flavour”, said Mr Ashish R. Patel, Whole-Time Director of Lincoln Pharmaceuticals Limited.
